Table 1.
Correlation between the ZEB1 and HDGF protein expression with the clinicopathologic Characteristics in EC
| Characteristics | ZEB1 (%) | HDGF (%) | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| N | Negative | Positive | P | N | Negative | Positive | P | |
| Age | ||||||||
| < 50 | 29 | 22 (75.86) | 7 (24.14) | 0.672 | 29 | 16 (55.17) | 13 (44.83) | 0.697 |
| ≥ 50 | 69 | 55 (79.71) | 14 (20.29) | 69 | 41 (59.42) | 28 (40.58) | ||
| Menopausal status | ||||||||
| Premenopausal | 49 | 39 (79.59) | 10 (20.41) | 0.806 | 49 | 31 (63.27) | 18 (36.73) | 0.306 |
| Postmenopausal | 49 | 38 (77.55) | 11 (22.45) | 49 | 26 (53.06) | 23 (46.94) | ||
| FIGO stage | ||||||||
| I-II | 79 | 73 (92.40) | 6 (7.60) | < 0.001 | 79 | 56 (70.89) | 23 (29.11) | < 0.001 |
| III | 19 | 4 (21.05) | 15 (78.95) | 19 | 1 (5.26) | 18 (94.74) | ||
| Histological grading | ||||||||
| G1+G2 | 85 | 69 (81.18) | 16 (18.82) | 0.108 | 85 | 55 (64.71) | 30 (35.29) | < 0.001 |
| G3 | 13 | 8 (61.54) | 5 (38.46) | 13 | 2 (15.38) | 11 (84.62) | ||
| Depth of myometrial invasion | ||||||||
| < 50% | 64 | 55 (85.94) | 9 (14.06) | 0.015 | 64 | 41 (64.06) | 23 (35.94) | 0.104 |
| ≥ 50% | 34 | 22 (64.71) | 12 (35.29) | 34 | 16 (47.06) | 18 (52.94) | ||
| Lymph node status | ||||||||
| Negative | 82 | 75 (91.46) | 7 (8.54) | < 0.001 | 82 | 56 (68.29) | 26 (31.71) | < 0.001 |
| Positive | 16 | 2 (12.5) | 14 (87.5) | 16 | 1 (6.25) | 15 (93.75) | ||